AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 176 filers reported holding AXSOME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12 | -7.7% | 175 | 0.0% | 0.00% | – |
| Q2 2023 | $13 | +18.2% | 175 | 0.0% | 0.00% | – |
| Q1 2023 | $11 | -15.4% | 175 | 0.0% | 0.00% | – |
| Q4 2022 | $13 | -99.8% | 175 | +35.7% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 129 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | 0.0% | 129 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 129 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | +25.0% | 129 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 129 | +84.3% | 0.00% | – |
| Q2 2021 | $5,000 | +25.0% | 70 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | -33.3% | 70 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | -60.0% | 70 | -66.5% | 0.00% | – |
| Q3 2020 | $15,000 | +36.4% | 209 | +7.2% | 0.00% | – |
| Q2 2020 | $11,000 | 0.0% | 195 | 0.0% | 0.00% | – |
| Q1 2020 | $11,000 | -45.0% | 195 | 0.0% | 0.00% | – |
| Q4 2019 | $20,000 | – | 195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |